ArticleACS physical chemistry Au2025
Coffee Silver Skin: A Useful Adsorbent Substrate for Norfloxacin Removal and Photodegradation.
Article in ACS physical chemistry Au, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This work proposes the use of Coffee Silver Skin, a by-product of coffee production, as an adsorbent substrate for the removal of the antibiotic Norfloxacin from water and assesses the possibility of regenerating it through advanced oxidation processes. In detail, the study was developed by showing the best conditions for the pollutant removal, in which the adsorption process occurred with the main involvement of electrostatic interactions. A preliminary desorption approach in the presence of salt-based solutions, i.e., NaCl and 0.1 M MgCl
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.